Perrigo Co. (0Y5E.L) Stock Analysis & Winston Score
Perrigo is a company that makes store-brand, over-the-counter medicines and health products. Think of the generic pain relievers, allergy pills, cough syrups, and baby formula you see under a grocery store or pharmacy's own label — Perrigo likely made them. Its main customers are large retailers like Walmart, CVS, and Walgreens, who sell these products under their own brand names instead of big-name brands like Tylenol or Advil. Perrigo earns money by manufacturing and selling these generic consumer health products, primarily across North America and Europe. It is one of the largest store-brand OTC healthcare suppliers in the world, which gives it scale advantages, though it faces constant pressure from both branded competitors and other generic makers. The company has been working to simplify its business after years of acquisitions left it with heavy debt, and reducing that debt load while defending its retail partnerships remains the central challenge going forward.
Winston Score: 18/100 — Weak
Weak fundamentals across most pillars.
- Quality: Weak (7/30)
- Growth: Weak (2/20)
- Cash Flow: Weak (1/10)
- Stability: Mixed (3/10)
- Valuation: Data not available (0/10)
- Ownership: Weak (2/15)
Key Facts
Price: $10.92
Market Cap: $1.5B
Sector: Healthcare
Industry: Medical - Pharmaceuticals
Exchange: London Stock Exchange

